Focus

CNM Ltd Ireland distribute, under the name "SwissmedicalCBD.com", products of Pharmotech SA a Swiss Laboratory of Phyto research and his focus is research and development (R&D) on the pharmacological antibacterial and others potential applications of the active principles produced by plants, especially by the Cannabis Sativa plant. Pharmotech produces and offers high quality leading products cannabinoids based as cremes and oils. Our products are natural and organic. Our main goal is to ensure continuity and reproducibility of the method and of quality of production: STANDARDISATION. The patent on CBD (cannabidiol) as antibacterial and anti-inflammatory we own on MDR bacteria, is a proof of evidence of our ability. CNM Ltd Ireland want to become in the next years the only leading company in the world, producing and distributing medical devices based on cannabinoids.

Strategy

CNM Ltd Ireland’s strategy is based on establishing a vertically integrated “Pharma” business model, with full traceability, building operations across all parts of the supply chain, including production operations, development of cannabinoids based drug-products and commercialisation. CNM Ltd Ireland supplies finished packaged and labelled product to its pharmaceutical or non, partners for the purposes of commercial distribution and sale.

If you have any question feel free to contact us at any time at info@pharmotech.ch, or just click here.

Pharmotech Team